Steven B Newhard

Title: The Innovative Contributions of Steven B Newhard

Introduction

Steven B Newhard, based in Scottsdale, AZ, is a notable inventor recognized for his contributions to pharmaceutical innovations. With a portfolio of five patents, Newhard has made significant strides in the development of topical compositions and advanced drug delivery systems.

Latest Patents

Among his latest patents is the innovative formulation titled "Topical compositions of flunisolide and methods of treatment". This patent presents compositions and methodologies aimed at treating or preventing various skin diseases by administering a topical flunisolide composition comprising a therapeutically effective amount of flunisolide alongside a solubilizing agent. Additionally, Newhard holds a patent for "Gastroretentive dosage forms for minocycline". This particular disclosure relates to dosage forms which enhance the absorption of minocycline within the gastrointestinal tract, thereby improving its bioavailability for treating conditions such as acne.

Career Highlights

Newhard has garnered valuable experience through his work at prominent companies in the pharmaceutical sector, including Medicis Pharmaceutical Corporation and Lupin, Inc. His role in these organizations has been fundamental in shaping his innovative approaches to drug formulation and delivery mechanisms.

Collaborations

Throughout his career, Steven has collaborated with esteemed professionals in the industry, including Mitchell S Wortzman and Douglas Anthony Bakan. These collaborations have allowed for the exchange of ideas and have fostered an environment conducive to innovation.

Conclusion

Steven B Newhard continues to be a significant figure in the field of pharmaceutical inventions. His commitment to developing effective treatment solutions demonstrates his dedication to enhancing patient care through innovative technologies. As he builds upon his existing patents and explores new concepts, his contributions remain a valuable asset to the industry.